Viltepso (Viltolarsen (viltolarsen) — Uses, Dosage, Side Effects & Safety

Drug class: Antisense oligonucleotide (exon-skipping agent)

Overview

Viltepso (viltolarsen) is a prescription medication used to treat Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. DMD is a rare, genetic muscle disorder that leads to progressive muscle weakness and loss of function, primarily affecting boys. Viltepso works by targeting the genetic mutation in the DMD gene, allowing the body to produce a shortened but functional form of the dystrophin protein. This helps slow the progression of muscle damage in eligible patients. Key points for patients: Viltepso is given as a weekly intravenous infusion under medical supervision. It is not a cure for DMD, but it may help preserve muscle function. Regular monitoring is required to check for side effects, especially effects on the kidneys.

Therapeutic uses

  • Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable to exon 53 skipping

Common side effects

  • Vomiting
  • Abdominal pain
  • Diarrhea
  • Fever
  • Upper respiratory tract infection
  • Cough
  • Kidney toxicity
  • Thrombocytopenia

Frequently Asked Questions about Viltepso (Viltolarsen

What is Viltepso used for?

Viltepso is used to treat Duchenne muscular dystrophy (DMD) in patients with a confirmed mutation amenable to exon 53 skipping.

How is Viltepso administered?

Viltepso is given as a weekly intravenous infusion by a healthcare professional in a clinic or hospital setting.

What are the most common side effects?

The most common side effects include upper respiratory tract infections, cough, and injection site reactions.

Can adults take Viltepso?

Viltepso is not approved for use in adults; its safety and efficacy have not been established in this population.

What should I do if I miss a dose?

Contact your healthcare provider as soon as possible to reschedule the missed infusion. Do not double up doses.

Are there any serious risks with Viltepso?

Yes, Viltepso can cause serious kidney problems and allergic reactions. Regular monitoring is required.

Can Viltepso cure Duchenne muscular dystrophy?

No, Viltepso is not a cure for DMD, but it may help slow disease progression in eligible patients.

Educational information only. Always consult a qualified healthcare professional before starting, stopping, or changing any medication.